BioSpace News Archive

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that Greenbrook TMS, a NeuroStar Advanced Therapy provider with 82 treatment centers across the U.S., has installed its 100th NeuroStar system.

Industry veteran brings extensive experience driving the commercialization of robotic technologies within healthcare

APR Applied Pharma Research s.a., the Swiss pharma company focused in specialized therapeutic areas and rare diseases, presents at the annual conference of SSIEM latest scientific data confirming benefits of PKU GOLIKE® in PKU management.

The Pancreatic Cancer Action Network, a leading patient advocacy organization, announced that Columbia Sportswear executive Lisa Kulok has joined its national board of directors.

Synlogic, Inc. announced presentation of the full clinical data set from healthy volunteers and patient cohorts of a randomized, double-blind, placebo-controlled Phase 1/2a study of SYNB1618, which is being developed as an oral therapy for the treatment of phenylketonuria.

Osmotica Pharmaceuticals plc, a fully integrated biopharmaceutical company, announced results of the Company’s Extraordinary General Meeting.

Alexion Pharmaceuticals announced that management will present at the 17th Annual Morgan Stanley Global Healthcare Conference in New York, NY on Monday, September 9th, 2019 at 8:45 a.m. ET.

Former President and COO of Celgene appointed independent director

World Class Eye Institute Positions ICL as Primary and Premium Vision Correction Procedure

The global Duchenne muscular dystrophy therapeutics market size is poised to reach USD 2.23 billion by 2023, according to a new report by Technavio, progressing at a CAGR of 37% during the forecast period.